EDGAR Filing Documents for 0001193125-19-039139

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

SEC Accession No. 0001193125-19-039139

Filing Date

2019-02-14

Accepted

2019-02-14 06:37:33

Documents

Group Members

JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND V, L.P.POLARIS VENTURE PARTNERS SPECIAL FOUNDERS FUND V, L.P.TERRANCE G. MCGUIRE

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D/A	d670596dsc13da.htm	SC 13D/A	125787
2	EX-99.A	d670596dex99a.htm	EX-99.A	10911
	Complete submission text file	0001193125-19-039139.txt		138604

Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210

Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 781-290-0770

Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140

Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191

GENOCEA BIOSCIENCES, INC. (Subject) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87984 | Film No.: 19600555
SIC: 2836 Biological Products, (No Diagnostic Substances)